Aarti Drugs Limited — Others, 18-07-2025: Appointment

Aarti Drugs' Board of Directors has approved the audited financial results for the quarter ended June 30, 2025. The Board also appointed a new secretarial audit firm for a period of five years. This significant decision enhances the company's corporate governance and compliance mechanisms, providing increased transparency and assurance for stakeholders. These actions reflect the company's ongoing commitment to strong financial reporting and regulatory adherence, offering investors a clearer picture of its operational integrity.